浏览全部资源
扫码关注微信
1.天津中医药大学,天津 301617
2.中国中医科学院 中药研究所,北京 100700
3.江西中医药大学 药学院,南昌 330004
4.北京城市学院,北京 100089
王艳静,在读硕士,从事中药制剂研究,E-mail:17865135012@163.com
刘德文,副研究员,硕士生导师,从事中药新药研发及新剂型研究,E-mail:dwliu@icmm.ac.cn
王锦玉,研究员,硕士生导师,从事中药新药研发及新剂型研究,E-mail:jinyu024@163.com
纸质出版日期:2023-10-20,
网络出版日期:2023-01-10,
收稿日期:2022-10-13,
扫 描 看 全 文
王艳静,欧则民,严林等.微乳对泽泻汤提取液不同相态中指标成分含量的影响[J].中国实验方剂学杂志,2023,29(20):134-140.
WANG Yanjing,OU Zemin,YAN Lin,et al.Effect of Microemulsion on Content of Index Components in Different Phases of Zexietang Extract[J].Chinese Journal of Experimental Traditional Medical Formulae,2023,29(20):134-140.
王艳静,欧则民,严林等.微乳对泽泻汤提取液不同相态中指标成分含量的影响[J].中国实验方剂学杂志,2023,29(20):134-140. DOI: 10.13422/j.cnki.syfjx.20230567.
WANG Yanjing,OU Zemin,YAN Lin,et al.Effect of Microemulsion on Content of Index Components in Different Phases of Zexietang Extract[J].Chinese Journal of Experimental Traditional Medical Formulae,2023,29(20):134-140. DOI: 10.13422/j.cnki.syfjx.20230567.
目的
2
基于高效液相色谱法(HPLC)及相态拆分工艺探讨微乳对泽泻汤提取液不同相态中指标成分分布的影响。
方法
2
采用粒径仪和透射电镜对空白微乳、泽泻汤水提液和泽泻汤微乳提取液中胶体粒子进行表征;采用高速离心法及透析法建立相态拆分工艺,并依据该工艺,将泽泻汤水提液和泽泻汤微乳提取液分别拆分为真溶液相态,胶体相态和沉淀相态;采用HPLC测定不同相态中白术内酯Ⅲ、白术内酯Ⅱ、23-乙酰泽泻醇C、泽泻醇A、泽泻醇B和23-乙酰泽泻醇B共6种指标成分的含量,流动相水(A)-乙腈(B)梯度洗脱(0~5 min,40%~43%B;5~20 min,43%~45%B;20~45 min,45%~60%B;45~75 min,60%~80%B);采用饱和溶解度方法测定泽泻汤指标成分在水和微乳溶剂中的溶解度。
结果
2
泽泻汤水提液、微乳提取液和空白微乳中的胶体粒子形态均呈圆球形,胶体粒子的粒径、多分散指数(PDI)和Zeta电位大小排序均为水提液>微乳提取液>空白微乳。相态拆分结果显示,透析2.5 h即可将胶体相态和真溶液相态拆分完全,经检验该工艺稳定可行。与泽泻汤水提液比较,以微乳作为提取溶剂可以提高白术内酯Ⅲ、23-乙酰泽泻醇C、白术内酯Ⅱ、泽泻醇A、泽泻醇B和23-乙酰泽泻醇B在胶体相态内的含量约3.75、6.82、35.47、10.66、35.41、27.75倍,并可提高后5种成分的提取效率2.03、1.15、1.70、6.43、5.53倍。溶解度试验显示,微乳能提高白术内酯Ⅱ、泽泻醇A、泽泻醇B和23-乙酰泽泻醇B的溶解度,但对白术内酯Ⅲ和23-乙酰泽泻醇C的溶解度影响较小。
结论
2
微乳可不同程度提高泽泻汤指标成分的提取效率并增加指标成分在胶体相态中的分布,为微乳作为中药提取溶剂的可行性提供参考。
Objective
2
To investigate the effect of microemulsion on the distribution of index components in different phases of Zexietang extract based on high performance liquid chromatography(HPLC) and phase separation process.
Method
2
Particle size meter and transmission electron microscope were used to characterize the colloidal particles in blank microemulsion, aqueous extract of Zexietang and microemulsion extract of Zexietang. The phase separation process was established by high-speed centrifugation and dialysis, and based on this process, the aqueous extract and microemulsion extract of Zexietang were separated into the true solution phase, the colloidal phase and the precipitation phase, respectively. The contents of six components, including atractylenolide Ⅲ, atractylenolide Ⅱ, 23-acetyl alisol C, alisol A, alisol B and alisol B 23-acetate, were determined by HPLC with the mobile phase of water(A)-acetonitrile(B) for gradient elution(0-5 min, 40%-43%B; 5-20 min, 43%-45%B; 20-45 min. 45%-60%B; 45-75 min, 60%-80%B). The solubility of the index components in water and microemulsion was determined by saturation solubility method.
Result
2
The colloidal particles in the aqueous extract, microemulsion extract and blank microemulsion were all spherical, and the particle size, polydispersity index(PDI) and Zeta potential of the colloidal particles were in the order of aqueous extract >microemulsion extract >blank microemulsion. The results of phase separation showed that the colloidal phase and the true solution phase could be completely separated by dialysis for 2.5 h, and the phase separation process was tested to be stable and feasible. Compared with the aqueous extract of Zexietang, the use of microemulsion as an extraction solvent could increase the contents of atractylenolide Ⅲ, 23-acetyl alisol C, atractylenolide Ⅱ , alisol A, alisol B and alisol B 23-acetate by 3.75, 6.82, 35.47, 10.66, 35.41, 27.75-fold, and could increase the extraction efficiencies of the latter five constituents by 2.03, 1.15, 1.70, 6.43, 5.53 times. The solubility test showed that the microemulsion could significantly improve the solubility of atractylenolide Ⅱ, alisol A, alisol B and alisol B 23-acetate, but it had less effect on the solubility of atractylenolide Ⅲ and 23-acetyl alisol C.
Conclusion
2
Microemulsion can improve the extraction efficiency and increase the distribution of the index components in the colloidal phase state of Zexietang to different degrees, providing a reference for the feasibility of microemulsion as an extraction solvent for traditional Chinese medicine.
泽泻汤微乳相态拆分工艺含量测定胶体粒子溶解度提取溶剂
Zexietangmicroemulsionphase separation processcontent determinationcolloidal particlessolubilityextraction solvent
PAUL B K,MOULIK S P.Microemulsions:An overview[J].J Disper Sci Technol,1997,18(4):301-367.
王金铃,孙进,何仲贵.微乳及其在药学中应用[J].中国药剂学杂志:网络版,2009,7(4):356-364.
吴顺芹,李三鸣,赵国斌.微乳及其在药剂学中的应用[J].沈阳药科大学学报,2003,20(5):381-385.
杨华,邓茂,易红.O/W型微乳用于提取中药丹参的实验研究[J].中国中药杂志,2008,33(22):2617-2622.
易红,孙立亚,高进,等.O/W型微乳用于厚朴提取的研究[J].中国实验方剂学杂志,2011,17(16):1-5.
高进,易红,杨华等.O/W型微乳用于提取中药当归[J].中国新药杂志,2011,20(6):503-507.
宋强,杜红,冯前进,等.中药微乳提取技术的初步实验研究[J].世界中西医结合杂志,2007,2(7):390-392.
何朝,浦益琼.中药复方汤液的相态差异分析研究进展[J].中国实验方剂学杂志,2022,28(15):259-266.
吕邵娃,武印奇,李英鹏,等.白虎汤相态拆分及不同相态中主要成分的含量测定[J].中国实验方剂学杂志,2020,26(11):154-160.
李莎莎,钟利群,夏梦幻.泽泻汤的相关研究概况[J].现代中医临床,2017,24(4):56-60.
严林,李新健,张冰冰,等.泽泻汤的研究现状[J].中国实验方剂学杂志,2021,27(16):191-197.
吴嘉朔,常晓燕,李壮壮,等.泽泻汤降脂及抗炎作用分子机制研究进展[J].中国实验方剂学杂志,2021,27(2):224-232.
王梦瑶,李二稳,高改,等.泽泻汤调控Akt/TFEB促进肝细胞脂噬机制研究[J].中国中药杂志,2022,47(22):6183-6190.
彭敏.泽泻汤对血脂调节的胆固醇相关基因mRNA表达变化研究[D].武汉:湖北中医药大学,2011.
郁相云,钟建华,张旭.泽泻降血脂药理作用及物质基础研究[J].中国中医药现代远程教育,2010,8(11):250-250.
乐智勇.泽泻汤降血脂作用机理研究[D].武汉:湖北中医药大学,2012.
王瑞雪,刘妍,张树峰.泽泻汤治疗原发性高血压的临床疗效及其机制研究进展[J].上海中医药杂志,2017,51(8):103-105,112.
吕金穗.泽泻中药汤辅助西药治疗原发性高血压的疗效评估[J].实用药物与临床,2013,16(7):629-630.
高怡,白如玉.泽泻加味方治疗高血压病临床疗效研究[J].中药药理与临床,2015,31(1):320-321.
赵赫,杨艳平,蔡青,等.加味泽泻汤联合敏使朗治疗痰湿型梅尼埃病[J].吉林中医药,2020,40(3):353-356.
郑伟,胡刚.真武汤合泽泻汤治疗梅尼埃病46例[J].世界最新医学信息文摘,2018,18(69):180,183.
唐文强,高艳蓉,杨长花,等.经典名方泽泻汤UPLC指纹图谱的建立[J].中国现代应用药学,2021,38(6):680-687.
武印奇,吕邵娃,李英鹏,等.白虎汤中纳米相态的分离与表征[J].中华中医药学刊,2021,39(12):121-124,286-289.
0
浏览量
17
下载量
0
CSCD
关联资源
相关文章
相关作者
相关机构